You just read:

Health Canada Approves IMBRUVICA™ by Priority Review, Giving Physicians and Patients a Much-Needed Option in the Fight Against Chronic Lymphocytic Leukemia

News provided by

Janssen Inc.

Nov 19, 2014, 07:00 ET